RSS feed

Publications by Peter J. Hemmersbach

52 publications found

Original articles

Hemmersbach P (2020)
The Probenecid-story - A success in the fight against doping through out-of-competition testing
Drug Test Anal, 12 (5), 589-594
DOI 10.1002/dta.2727, PubMed 31797550

Krogh N, Rzeppa S, Dyreborg A, Dehnes Y, Hemmersbach P, Backer V, Hostrup M (2017)
Terbutaline Accumulates in Blood and Urine after Daily Therapeutic Inhalation
Med Sci Sports Exerc, 49 (6), 1236-1243
DOI 10.1249/MSS.0000000000001199, PubMed 28072631

Dyreborg A, Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M (2016)
Pharmacokinetics of Oral and Inhaled Terbutaline after Exercise in Trained Men
Front Pharmacol, 7, 150
DOI 10.3389/fphar.2016.00150, PubMed 27375484

Kreiberg M, Becker V, Jessen S, Rzeppa S, Hemmersbach P, Backer V, Hostrup M (2016)
Influence of exercise in normal and hot ambient conditions on the pharmacokinetics of inhaled terbutaline in trained men
Scand J Med Sci Sports, 27 (7), 692-703
DOI 10.1111/sms.12697, PubMed 27167471

Krogh N, Backer V, Rzeppa S, Hemmersbach P, Hostrup M (2016)
Pharmacokinetics of nebulized and oral procaterol in asthmatic and non-asthmatic subjects in relation to doping analysis
Drug Test Anal, 8 (10), 1056-1064
DOI 10.1002/dta.1935, PubMed 26990656

Haase CB, Backer V, Kalsen A, Rzeppa S, Hemmersbach P, Hostrup M (2015)
The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis
Drug Test Anal, 8 (7), 613-20
DOI 10.1002/dta.1828, PubMed 26044066

Rzeppa S, Heinrich G, Hemmersbach P (2015)
Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry
Drug Test Anal, 7 (11-12), 1030-9
DOI 10.1002/dta.1895, PubMed 26472592

Hullstein IR, Malerod-Fjeld H, Dehnes Y, Hemmersbach P (2015)
Black market products confiscated in Norway 2011-2014 compared to analytical findings in urine samples
Drug Test Anal, 7 (11-12), 1025-9
DOI 10.1002/dta.1900, PubMed 26607218

Kalsen A, Hostrup M, Karlsson S, Hemmersbach P, Bangsbo J, Backer V (2014)
Effect of inhaled terbutaline on substrate utilization and 300-kcal time trial performance
J Appl Physiol (1985), 117 (10), 1180-7
DOI 10.1152/japplphysiol.00635.2014, PubMed 25257871

Hostrup M, Kalsen A, Bangsbo J, Hemmersbach P, Karlsson S, Backer V (2014)
High-dose inhaled terbutaline increases muscle strength and enhances maximal sprint performance in trained men
Eur J Appl Physiol, 114 (12), 2499-508
DOI 10.1007/s00421-014-2970-2, PubMed 25113095

Dehnes Y, Myrvold L, Ström H, Ericsson M, Hemmersbach P (2014)
MAIIA EPO SeLect-a rapid screening kit for the detection of recombinant EPO analogues in doping control: inter-laboratory prevalidation and normative study of athlete urine and plasma samples
Drug Test Anal, 6 (11-12), 1144-50
DOI 10.1002/dta.1752, PubMed 25421537

Hullstein I, Sagredo C, Hemmersbach P (2014)
Carbon isotope ratios of nandrolone, boldenone, and testosterone preparations seized in Norway compared to those of endogenously produced steroids in a Nordic reference population
Drug Test Anal, 6 (11-12), 1163-9
DOI 10.1002/dta.1745, PubMed 25388436

Hostrup M, Kalsen A, Auchenberg M, Rzeppa S, Hemmersbach P, Bangsbo J, Backer V (2013)
Urine concentrations of oral salbutamol in samples collected after intense exercise in endurance athletes
Drug Test Anal, 6 (6), 528-32
DOI 10.1002/dta.1568, PubMed 24166762

Lund H, Snilsberg AH, Halvorsen TG, Hemmersbach P, Reubsaet L (2013)
Comparison of newly developed immuno-MS method with existing DELFIA(®) immunoassay for human chorionic gonadotropin determination in doping analysis
Bioanalysis, 5 (5), 623-30
DOI 10.4155/bio.13.8, PubMed 23425277

Eibye K, Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2013)
Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations
Med Sci Sports Exerc, 45 (1), 16-22
DOI 10.1249/MSS.0b013e318269fba2, PubMed 22843108

Lund H, Snilsberg AH, Paus E, Halvorsen TG, Hemmersbach P, Reubsaet L (2012)
Sports drug testing using immuno-MS: clinical study comprising administration of human chorionic gonadotropin to males
Anal Bioanal Chem, 405 (5), 1569-76
DOI 10.1007/s00216-012-6566-6, PubMed 23203507

Elers J, Hostrup M, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2012)
Urine and serum concentrations of inhaled and oral terbutaline
Int J Sports Med, 33 (12), 1026-33
DOI 10.1055/s-0032-1311590, PubMed 22782385

Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2012)
The pharmacokinetic profile of inhaled and oral salbutamol in elite athletes with asthma and nonasthmatic subjects
Clin J Sport Med, 22 (2), 140-5
DOI 10.1097/JSM.0b013e31823513e1, PubMed 22388343

Elers J, Pedersen L, Henninge J, Hemmersbach P, Dalhoff K, Backer V (2011)
Urine concentrations of repetitive doses of inhaled salbutamol
Int J Sports Med, 32 (8), 574-9
DOI 10.1055/s-0031-1273755, PubMed 21563035

Dehnes Y, Hemmersbach P (2011)
Effect of single doses of methoxypolyethylene glycol-epoetin beta (CERA, Mircera™) and epoetin delta (Dynepo™) on isoelectric erythropoietin profiles and haematological parameters
Drug Test Anal, 3 (5), 291-9
DOI 10.1002/dta.270, PubMed 21387570

Elers J, Pedersen L, Henninge J, Lund TK, Hemmersbach P, Dalhoff K, Backer V (2010)
Blood and urinary concentrations of salbutamol in asthmatic subjects
Med Sci Sports Exerc, 42 (2), 244-9
DOI 10.1249/MSS.0b013e3181b2e87d, PubMed 19927035

Henninge J, Pepaj M, Hullstein I, Hemmersbach P (2010)
Identification of CJC-1295, a growth-hormone-releasing peptide, in an unknown pharmaceutical preparation
Drug Test Anal, 2 (11-12), 647-50
DOI 10.1002/dta.233, PubMed 21204297

Juul A, Sørensen K, Aksglaede L, Garn I, Rajpert-De Meyts E, Hullstein I, Hemmersbach P, Ottesen AM (2008)
A common deletion in the uridine diphosphate glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys
J Clin Endocrinol Metab, 94 (3), 1005-11
DOI 10.1210/jc.2008-1984, PubMed 19088161

Hintikka L, Kuuranne T, Leinonen A, Thevis M, Schänzer W, Halket J, Cowan D, Grosse J, Hemmersbach P, Nielen MW, Kostiainen R (2008)
Liquid chromatographic-mass spectrometric analysis of glucuronide-conjugated anabolic steroid metabolites: method validation and interlaboratory comparison
J Mass Spectrom, 43 (7), 965-73
DOI 10.1002/jms.1434, PubMed 18563858

Morkeberg J, Lundby C, Nissen-Lie G, Nielsen TK, Hemmersbach P, Damsgaard R (2007)
Detection of darbepoetin alfa misuse in urine and blood: a preliminary investigation
Med Sci Sports Exerc, 39 (10), 1742-7
DOI 10.1249/mss.0b013e31811e9d55, PubMed 17909401

Hemmersbach P, Hågensen Jetne AH, Lund HS (2006)
Determination of urinary norandrosterone excretion in females during one menstrual cycle by gas chromatography/mass spectrometry
Biomed Chromatogr, 20 (8), 710-7
DOI 10.1002/bmc.586, PubMed 16229056

Grosse J, Anielski P, Hemmersbach P, Lund H, Mueller RK, Rautenberg C, Thieme D (2005)
Formation of 19-norsteroids by in situ demethylation of endogenous steroids in stored urine samples
Steroids, 70 (8), 499-506
DOI 10.1016/j.steroids.2005.01.005, PubMed 15894033

Nissen-Lie G, Birkeland K, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary r-hEPO in doping control
Med Sci Sports Exerc, 36 (4), 588-93
DOI 10.1249/01.mss.0000121953.90379.a7, PubMed 15064585

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
Med Sci Sports Exerc, 32 (7), 1238-43
DOI 10.1097/00005768-200007000-00009, PubMed 10912888

Birkeland KI, Hemmersbach P (1999)
The future of doping control in athletes. Issues related to blood sampling
Sports Med, 28 (1), 25-33
DOI 10.2165/00007256-199928010-00003, PubMed 10461710

Haug E, Hemmersbach P, Birkeland K (1999)
[Glimpses from the history of doping in sports]
Tidsskr Nor Laegeforen, 119 (17), 2538-40
PubMed 10425911

Reubsaet KJ, Ragnar Norli H, Hemmersbach P, Rasmussen KE (1998)
Determination of benzodiazepines in human urine and plasma with solvent modified solid phase micro extraction and gas chromatography; rationalisation of method development using experimental design strategies
J Pharm Biomed Anal, 18 (4-5), 667-80
DOI 10.1016/s0731-7085(98)00275-1, PubMed 9919968

Tomten SE, Falch JA, Birkeland KI, Hemmersbach P, Høstmark AT (1998)
Bone mineral density and menstrual irregularities. A comparative study on cortical and trabecular bone structures in runners with alleged normal eating behavior
Int J Sports Med, 19 (2), 92-7
DOI 10.1055/s-2007-971888, PubMed 9562216

Birkeland KI, Donike M, Ljungqvist A, Fagerhol M, Jensen J, Hemmersbach P, Oftebro H, Haug E (1997)
Blood sampling in doping control. First experiences from regular testing in athletics
Int J Sports Med, 18 (1), 8-12
DOI 10.1055/s-2007-972587, PubMed 9059898

Norli HR, Esbensen K, Westad F, Birkeland KI, Hemmersbach P (1995)
Chemometric evaluation of urinary steroid profiles in doping control
J Steroid Biochem Mol Biol, 54 (1-2), 83-8
DOI 10.1016/0960-0760(95)00114-f, PubMed 7632620

Birkeland KI, Jørgensen J, Hemmersbach P (1994)
[Endocrine effects of doping with androgenic anabolic steroids]
Tidsskr Nor Laegeforen, 114 (4), 426-8
PubMed 8009475

STOCKER M, HEMMERSBACH P, RAEDER JH, GREPSTAD JK (1986)
ISOMERIZATION OF N-BUTANE OVER ZEOLITES DEPENDING ON CATALYST STRUCTURE
APPL CATAL, 25 (1-2), 223-230
DOI 10.1016/S0166-9834(00)81240-3

Review articles

Hemmersbach P, Grosse J (2010)
Nandrolone: a multi-faceted doping agent
Handb Exp Pharmacol (195), 127-54
DOI 10.1007/978-3-540-79088-4_6, PubMed 20020363

Thevis M, Hemmersbach P, Geyer H, Schänzer W (2009)
[Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008]
Med Klin (Munich), 104 (12), 918-24
DOI 10.1007/s00063-009-1190-8, PubMed 20039158

Hemmersbach P (2008)
History of mass spectrometry at the Olympic Games
J Mass Spectrom, 43 (7), 839-53
DOI 10.1002/jms.1445, PubMed 18570181

Hemmersbach P, de la Torre R (1996)
Stimulants, narcotics and beta-blockers: 25 years of development in analytical techniques for doping control
J Chromatogr B Biomed Appl, 687 (1), 221-38
DOI 10.1016/s0378-4347(96)00276-9, PubMed 9001968

Other articles

Hemmersbach P (2020)
Mats Garle
Drug Test Anal, 12 (11-12), 1543
DOI 10.1002/dta.2922, PubMed 33006237

Bjørner T, Anwar T, Brede WR, Hemmersbach P, Slørdal L (2015)
[A man with a changed appearance]
Tidsskr Nor Laegeforen, 135 (3), 243-5
DOI 10.4045/tidsskr.14.0886, PubMed 25668542

Hemmersbach P, Drange M, Rabin O, Botrè F, Dehnes Y (2012)
Doping analysis on solid ground
Tidsskr Nor Laegeforen, 132 (2), 130
DOI 10.4045/tidsskr.11.1330, PubMed 22278263

Hemmersbach P (2011)
The 29th Manfred Donike workshop on doping analysis
Drug Test Anal, 3 (11-12), 755
DOI 10.1002/dta.401, PubMed 22213683

Hemmersbach P (2004)
New analytical challenges in doping control. The situation after the Olympic Games in Athens
Med. Sport, 57 (3), 278

Segura J, Hemmersbach P, Sonksen P (1997)
Sports drug testing - A report on the 1st International Symposium on Advances in Dope Testing Research, held in Lausanne, Switzerland, 22-23 April 1997.
Trac-Trends Anal. Chem., 16 (7), R6-R7
DOI 10.1016/S0165-9936(97)82858-0

Haug E, Birkeland KI, Hemmersbach P (1996)
[Doping legislation]
Tidsskr Nor Laegeforen, 116 (2), 297-8
PubMed 8633342

Book chapters

Nissen-Lie G, Birkeland KI, Hemmersbach P, Skibeli V (2004)
Serum sTfR levels may indicate charge profiling of urinary R-hEPO in doping control
In Medicine and science in sports and exercise, American College of Sports Medicine, Madison, 36(2004)4, S. 588-93
BIBSYS 051823705

Hemmersbach P (2003)
Analytiske muligheter og grenser for bevisføring: fremskritt innen dopinganalyse som svar på nye utfordringer
In Kjemi: prosjekt, prosess, produkt, Media Oslo, Oslo, 63(2003)1, s.19-23
BIBSYS 041716221

Berg JP, Hemmersbach P (2003)
Dopingkontroll
In Gen-i-alt, Bioteknologinemnden, Oslo, 12(2003)4, s.14-15
BIBSYS 041705459

Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallén J, Haug E, Bahr R (2000)
Effect of rhEPO administration on serum levels of sTfR and cycling performance
In Medicine and science in sports and exercise, American College of Sports Medicine, Madison, 32(2000)nr 7, s.1238-1243
BIBSYS 010829059